Justin Yan Chen
Chief Operating Officer at Tongjitang Chinese Medicines Co.
Profile
Justin Yan Chen is currently the Chief Operating Officer & Executive Director at Tongjitang Chinese Medicines Co. He previously worked as the Head-Project Investment at Citychamp Watch & Jewellery Group Ltd.
Mr. Chen holds an MBA from the University of Lancaster and an undergraduate degree from the University of International Business & Economics.
Justin Yan Chen active positions
| Companies | Position | Start |
|---|---|---|
Tongjitang Chinese Medicines Co.
 Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | Chief Operating Officer | 2009-12-06 |
Former positions of Justin Yan Chen
| Companies | Position | End |
|---|---|---|
| CITYCHAMP WATCH & JEWELLERY GROUP LIMITED | Corporate Officer/Principal | - |
Training of Justin Yan Chen
| University of Lancaster | Masters Business Admin |
| University of International Business & Economics | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CITYCHAMP WATCH & JEWELLERY GROUP LIMITED | Producer Manufacturing |
| Private companies | 1 |
|---|---|
Tongjitang Chinese Medicines Co.
Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | Health Technology |
- Stock Market
- Insiders
- Justin Yan Chen
